Brief: Medexus Says Triamcinolone Hexacetonide Injectable Suspension Approved For Public Reimbursement In Canada

Medexus Pharmaceuticals

08/04/2020 13:41

April 8 (Reuters) - Medexus Pharmaceuticals Inc  MDP.V :
    * MEDEXUS REPORTS TRIAMCINOLONE HEXACETONIDE INJECTABLE
SUSPENSION
APPROVED FOR PUBLIC REIMBURSEMENT IN CANADA
    * MEDEXUS PHARMACEUTICALS - PUBLIC REIMBURSEMENT OF
TRIAMCINOLONE
HEXACETONIDE INJECTABLE SUSPENSION TO ROLL OUT IN RESPECTIVE
PROVINCES OVER COMING MONTHS

Source text for Eikon:  ID:nGNX1mb1B3 
Further company coverage:  MDP.V 

 ((Reuters.Briefs@thomsonreuters.com;))